Investigating T Cell Immune Dynamics and IL-6's Duality in a Microfluidic Lung Tumor Model

Area of Science:

• Immunology
• Cell Biology
• Biomedical Engineering

Background:

• Interleukin 6 (IL-6) is a key cytokine involved in immune responses, T cell trafficking, and inflammation.
• Understanding IL-6's complex role in the tumor microenvironment is critical for therapeutic development.
• Cytokine concentrations significantly impact T cell differentiation, activation, and function.

Purpose of the Study:

• To investigate the dynamic effects of varying Interleukin 6 (IL-6) concentration gradients on CD4+ T cell activation and immune cell behavior.
• To analyze the dose-dependent responses of cancer cells and T cells to IL-6 in a controlled 3D culture system.
• To elucidate how IL-6 gradients modulate T cell phenotypes, cytokine production, and cell-cell interactions.

Main Methods:

• Development of a flow-based microsystem for controlled 3D cell culture.
• Exposure of CD4+ T cells and cancer cells (A549) to distinct IL-6 concentration gradients.
• Quantification of cell expansion, migration rates, CD marker expression (CD69, PD-1), and cytokine production (IFN-γ, TNF-α).

Main Results:

• Cancer cell (A549) expansion and Jurkat T cell migration were sensitive and dose-dependent to IL-6 gradients.
• Higher IL-6 concentrations (100 ng) led to rapid A549 expansion, potentially inhibiting Jurkat cell mobility.
• IL-6 gradients modulated CD marker expression and increased pro-inflammatory cytokine (IFN-γ, TNF-α) levels in CD4+ T cells.

Conclusions:

• Interleukin 6 (IL-6) concentration gradients play a crucial role in modulating T helper cell activation, phenotype, and inflammatory responses.
• IL-6 influences phenotypic heterogeneity and cytokine production in T cells, impacting immune response dynamics.
• This study provides insights into IL-6's intricate role in immune modulation within experimental settings, relevant to tumor immunology.